Orthobond unveils antimicrobial surface technology at AAOS Annual Meeting
Click Here to Manage Email Alerts
Orthobond unveiled its pathogen-destroying antimicrobial nanosurface technology at the American Academy of Orthopaedic Surgeons Annual Meeting, according to a release.
The surface technology is the only non-eluting and non-antibiotic treatment designed for medical implants and is designed rupture pathogens on medical devices. The technology reportedly uses a powerful covalent linker technology to create an effective antimicrobial with the potential to improve outcomes in areas that use implantable devices such as orthopedics, cardiovascular and plastic surgery, according to the release.
“Orthobond’s technology creates a covalently bound nanosurface that is designed to kill bacteria, viruses and fungi, yet is safe for human contact,” David Nichols, CEO of Orthobond, said in the release. “Our first products will be a series of antimicrobial medical device surface treatments designed to protect from pathogens without the use of drugs or eluting chemicals, but long term we see broad applications for textiles, consumer goods and high-touch areas in public places.”
Orthobond expects to complete safety and efficacy testing for FDA marketing submission of its pathogen-killing technology later this year, according to the release.
Read more about
Click Here to Manage Email Alerts